Bio Protech Inc. (XKON:199290)
399.00
-1.00 (-0.25%)
At close: Oct 1, 2026
Bio Protech Market Cap
Bio Protech has a market cap or net worth of 5.77 billion as of October 1, 2026. Its market cap has decreased by -29.88% in one year.
Market Cap
5.77B
Enterprise Value
n/a
Revenue
20.58B
Ranking
n/a
PE Ratio
2.01
Stock Price
399.00
ChartMarket Cap Chart
Since April 5, 2017, Bio Protech's market cap has decreased from 7.43B to 5.77B, a decrease of -22.30%. That is a compound annual growth rate of -2.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 5.77B | -20.04% |
| Dec 29, 2025 | 7.22B | -16.83% |
| Dec 27, 2024 | 8.68B | -34.07% |
| Dec 28, 2023 | 13.16B | -15.35% |
| Dec 28, 2022 | 15.55B | 315.38% |
| Dec 30, 2021 | 3.74B | -54.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| RecensMedical | 96.80B |
| Corentec | 63.48B |
| DENTIS CO.,Ltd | 41.34B |
| Finemedix | 34.21B |
| Sanigen Co. | 29.75B |
| Genolution | 26.81B |
| TASCOM | 22.85B |
| Alpha AI | 10.45B |